@marcbesselink.bsky.social @tfstoop.bsky.social
Full text: jnccn.org/configurable...
@simoneaug.bsky.social
@marcbesselink.bsky.social @tfstoop.bsky.social
Full text: jnccn.org/configurable...
In JNCCN our nationwide study on quality of life in patients with locally advanced PDAC π³π±
βοΈ QoL remains stable over time, regardless of receiving treatment (89%)
π± Symptoms significantly deteriorate and deserve attention
β‘οΈ Use in shared decision making
@dpcgofficial.bsky.social